Home / Central Data Catalog / IMPACT_EVALUATION / TJK_2014_HRBFIE-FBL_V01_M
impact_evaluation

Health Results Based Financing Impact Evaluation 2014, Health Facility Baseline Survey

Tajikistan, 2014 - 2015
Get Microdata
Reference ID
TJK_2014_HRBFIE-FBL_v01_M
DOI
https://doi.org/10.48529/s143-rw94
Producer(s)
Damien de Walque, Aneesa Arur, Gil Shapira
Collection(s)
Impact Evaluation Surveys
Metadata
Documentation in PDF DDI/XML JSON
Created on
Mar 30, 2017
Last modified
Mar 30, 2017
Page views
273833
Downloads
14820

Data file: f23_cba_hypertension

Criterion Based Audit: CBA1 - Hypertension

Cases: 574
Variables: 59

Variables

REGION
Region
DISTRICT
District
FACILITY
Facility number
C1_4_DD
c1.4_dd
C1_4_MM
c1.4_mm
C1_4_YY
c1.4_yy
C1_5
Patient code
C1_6
Patient's gender
C1_7
Is patient's age recorded in the Medical History form?
C1_7A_DD
c1.7a_dd
C1_7A_MM
c1.7a_mm
C1_7A_YY
c1.7a_yy
AGE
AGE
C1_8
Please identify the age of the patient as per categories given below:
C1_9_01
Patient's problems (symptoms)
C1_9_02
Blood pressure
C1_9_03
Nausea
C1_9_04
Vomiting
C1_9_05
Oliguria
C1_9_06
Vision problems
C1_9_07
Chest pain
C1_9_08
Smoking status
C1_9_09
Alcohol intake, quantity and frequency
C1_9_10
Family history of premature coronary heart disease or stroke
C1_9_11
Diabetes status (absence /presence)
C1_9_12
Measures weight
C1_9_13
Presence of kidney diseases
C1_9_14
Lifestyle /physical activity
C1_9_15
Food intake/diet
C1_9_16
Weight gain/loss
C1_9_17
Taking antihypertensive therapy
C1_9_18
Taking other medicines
C1_9_19
When for the first time such symptoms were presented
C1_10_01
Weight
C1_10_02
Blood pressure
C1_10_03
Edema
C1_10_04
Pulse
C1_10_05
Urine test results on Albumin
C1_10_06
Urine test results on creatinine
C1_10_07
Urine test results on hematuria
C1_10_08
Blood test results on plasma glucose
C1_10_09
Blood test results on electrolytes
C1_10_10
Blood test results on glomerular filtration rate
C1_10_11
Blood test results on serum total cholesterol and HDL cholesterol
C1_10_12
Total blood cholesterol
C1_10_13
Other not listed above
C1_10_OTHER
c1.10_OTHER
C1_11
Is the cardio vascular risk estimated and recorded?
C1_12
Please record the CVD risk level defined in patient's medical history form
C1_13
Was the cardiovascular risk estimated correctly?
C1_14_1
ANTIHYPERTENSIVE DRUGS
C1_14_2
LIPID LOWERING DRUGS (STATINS):
C1_14_3
HYPOGLYCEMIC DRUGS:
C1_14_4
ANTIPLATELETE DRUGS
C1_14_5
HORMONE REPLACEMENT
C1_14_6
VITAMIN B
C1_14_7
VITAMIN C
C1_14_8
VITAMIN E
C1_14_9
FOLIC ACID SUPPLEMENTS
Total: 59
Back to Catalog

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.